WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER

The Institute of Alcohol Studies have published a new video explaining the impact of alcohol on our healthcare services.

The video features Julia Sinclair, Professor of Addiction Psychiatry and Chair of the RCPsych Addiction Faculty, Dr Dominique Florin, Medical Director of the Medical Council on Alcohol and Sir Ian Gilmore, Profess or of Hepatology and Chair of the AHA and the MCA, and explores service fragmentation, the consequences of underfunding, and the steps needed to rebuild effective pathways to care. It makes the case for a national alcohol strategy to ensure that people experiencing alcohol dependence receive the support they need.

View on YouTube here > The Impact of Alcohol on our Healthcare Services: Explained.

Or on the Institute of Alcohol Studies website.

Calling all innovators in Cancer Surgery

BASO~ACS proudly announces the opening of submissions for 2025 round of the BASO/Rosetrees Research Grants in Cancer Surgery, in partnership with esteemed Rosetrees Trust.

They are seeking innovative research projects in surgical oncology that will develop further towards Clinical Translation.  They invite multidisciplinary applications and ones that demonstrate an important improvement in delivery of cancer care or improvement in surgical treatment.

Up to £50,000 is up for grabs! This generous amount will be divided among one or more deserving applicants, based on the excellence of submissions received.

Successful projects will be eligible for inclusion in the NIHR Portfolio. Plus, we encourage applicants to seek support from the esteemed Royal College of Surgeons of England Surgical SITU Interventional Trials Unit (SITU).

Submission closes on 2nd May 2025.

For information on the grant process, eligibility, and to apply, visit BASO Website or email us at admin@baso.org.uk .

Exciting Announcement!!!

I am delighted to announce that Frontline Gastroenterology (FG, fg.bmj.com) will become the official journal partner of BASL!! There has been a desire to set-up a BASL journal for a number of years, but there have always been challenges that have prevented this, the predominant one being the initial set up costs. Productive discussions were started with FG in mid-to late 2024 and it soon became apparent that the aspirations of FG and BASL aligned closely.

FG will remain a broadly cross subspecialty journal, publishing high quality gastroenterology, hepatology, and nutrition original research and reviews, but there is a clear and strong focus to develop and encourage the submission and publication of liver related articles and release special issues as a major strategic goal of the journal as it aims to grow and increase its impact factor and metrics.

I am grateful to the FG Editor in Chief Dr Philip Smith and the senior publisher at BMJ group for their enthusiasm, flexibility and support in setting this up.

Dr Philip Smith states, "I am delighted that BASL and FG are affiliating. I am firmly committed to publishing the very best frontline Hepatology content that is submitted to FG from around the globe, and have a fantastic Hepatology Associate Editor team (including BASL representation) who are striving to do the same. Working together with BASL is a huge positive for both FG and BASL and I am very excited to see what the future holds. I am grateful to the BASL team and Dr Tim Cross, BASL President for helping to make this happen. I will be proud to see the BASL logo within the journal going forward!"

We very much look forward to working together in the future and will strive to deliver high quality articles and original research to better serve our patients and membership.

Tim Cross
BASL President